This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
HIV Clinical Trials
Download PDF
Print
Journal Information
Journal Title
HIV Clinical Trials
Publisher
Taylor & Francis
ISSN
1528-4336
E-ISSN
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
2025
2024
2023
2021/2022
2020
2019
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry
Jenny Bischoff, Stefan Mauss, Christiane Cordes et al.
2018-11-2
Vol. 19
Issue 6
Pages 225-234
DOI:
10.1080/15284336.2018.1538193
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial
Risa M. Hoffman, Konstantia Nadia Angelidou, Sean S. Brummel et al.
2018-11-2
Vol. 19
Issue 6
Pages 209-224
DOI:
10.1080/15284336.2018.1537327
Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006)
Jack E. Burkhalter, David M. Aboulafia, Maria Botello-Harbaum et al.
2018-11-2
Vol. 19
Issue 6
Pages 235-241
DOI:
10.1080/15284336.2018.1537349
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects
Amedeo F. Capetti, Giuseppe V. De Socio, Maria V. Cossu et al.
2018-11-2
Vol. 19
Issue 6
Pages 242-248
DOI:
10.1080/15284336.2018.1550290
Natural control of HIV infection in young women in South Africa: HPTN 068
Mariya V. Sivay, Jessica M. Fogel, Jing Wang et al.
2018-9-3
Vol. 19
Issue 5
Pages 202-208
DOI:
10.1080/15284336.2018.1531534
Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults
Zao Zhang, Glen M. Chew, Cecilia M. Shikuma et al.
2018-9-3
Vol. 19
Issue 5
Pages 172-176
DOI:
10.1080/15284336.2018.1514821
Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Quirico Mela, Valeria Ruggiero, Lorenza Montaldo et al.
2018-9-3
Vol. 19
Issue 5
Pages 188-196
DOI:
10.1080/15284336.2018.1525841
Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system
Michael A. Horberg, Allison H. Oakes, Leo B. Hurley et al.
2018-9-3
Vol. 19
Issue 5
Pages 177-187
DOI:
10.1080/15284336.2018.1523826
Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study
Joshua Wynne, Rosemary Muwawu, Michael C Mubiru et al.
2018-9-3
Vol. 19
Issue 5
Pages 165-171
DOI:
10.1080/15284336.2018.1513711
Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy
Álvaro Mena, Purificación Cid, Carlos Dueñas et al.
2018-9-3
Vol. 19
Issue 5
Pages 197-201
DOI:
10.1080/15284336.2018.1513974
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 17, 2026 01:29